TH-015

N/A

Report date: 2022/12/09 14:20:48

Base Information

Drug NameTH-015
Drug Alias NameTH-015
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCarcinoembryonic antigen-related cell adhesion molecule 7 modulators
TargetsCarcinoembryonic antigen-related cell adhesion molecule 7
Therapy Area/IndicationsStrokeSepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShandong Bangentai Biomedical Tech Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Bangentai Biomedical Tech Group Co Ltd
Inactive CompaniesN/A
Active IndicationsStrokeSepsis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A